Advertisement
Advertisement

IDYA

IDYA logo

IDEAYA Biosciences, Inc. Common Stock

27.60
USD
Sponsored
-0.47
-1.67%
Jun 10, 15:59 UTC -4
Closed
exchange

Pre-Market

27.98

+0.38
+1.36%

IDYA Earnings Reports

Positive Surprise Ratio

IDYA beat 12 of 28 last estimates.

43%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$5.73M
/
-$1.10
Implied change from Q1 26 (Revenue/ EPS)
-12.66%
/
-0.90%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+25.00%

IDEAYA Biosciences, Inc. Common Stock earnings per share and revenue

On May 05, 2026, IDYA reported earnings of -1.11 USD per share (EPS) for Q1 26, missing the estimate of -1.00 USD, resulting in a -10.01% surprise. Revenue reached 6.56 million, compared to an expected 5.38 million, with a 21.93% difference. The market reacted with a -0.35% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -1.10 USD, with revenue projected to reach 5.73 million USD, implying an decrease of -0.90% EPS, and decrease of -12.66% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
For Q1 2026, IDEAYA Biosciences, Inc. Common Stock reported EPS of -$1.11, missing estimates by -10.01%, and revenue of $6.56M, 21.93% above expectations.
The stock price moved down -0.35%, changed from $28.90 before the earnings release to $28.80 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 9 analysts, IDEAYA Biosciences, Inc. Common Stock is expected to report EPS of -$1.10 and revenue of $5.73M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement